- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05066295
Validation and Reliability of the Parents Assessment of Protective Factors Survey
Strengthening Families to Prevent Child Neglect and Abuse With Community Based Protective Approaches: Culturally Appropriate Program Development and Educational Design
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The American Center for Social Policy Studies (CSSP) Center for Quality Improvement in Early Childhood (QIC_EC) defined protective factors that will form the basis of programs designed to prevent neglect and abuse, with community-based approaches. Community-based programs for primary prevention should be developed to prevent neglect and abuse, before it occurs. Existing studies in our country show that there is rarely a focus on preventing adverse childhood experiences with primary preventive approaches. Most of the studies are school-based, and aimed at increasing awareness of children and families about abuse.
This study aimed to evaluate the Turkish translation of the PAPF survey for validity and reliability and to adapt a culturally appropriate program and educational design for strengthening families, with a multidisciplinary team.
In the first step of the study, Turkish validity and reliability of the Parents Assessment of Protective Factors (PAPF) survey, will be conducted and applied to parents to determinate the protective factors. Turkish version of Adverse Childhood Experience Questionnaire (ACE), will be applied simultaneously with the PAPF survey, to identify adverse childhood experiences of parents that might affect parental resilience, parenting characteristics, and family dynamics.
In the second phase of the study, community-based family education programs that are currently being implemented in different countries will be reviewed by a multidisciplinary team (healthcare professionals, social workers and non-governmental organizations). A culturally appropriate educational primary prevention program for child neglect and abuse will be developed.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
-
Istanbul, Kalkun
- Marmara University School of Medicine
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Parents of children aged between 0 to 8 years
- Ability to read and complete the self-assessment questionnaires
Exclusion Criteria:
- Parents who do not give consent to participate in the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Turkish Validation of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: Baseline
|
Parents Assessment of Protective Factors (PAPF) Survey will be validated
|
Baseline
|
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: Baseline
|
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
|
Baseline
|
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Tidsramme: at 6 months
|
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
|
at 6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Subscale scores for each protective factors
Tidsramme: Baseline
|
Parents Assessment of Protective Factors (PAPF) Survey subscale scores will be computed.
Higher scores indicate greater protective factors.
|
Baseline
|
Protective Factors Index (PFI)
Tidsramme: Baseline
|
Parents Assessment of Protective Factors (PAPF) Survey total scores will be summed
|
Baseline
|
Adverse Childhood Events
Tidsramme: Baseline
|
Adverse Childhood Events will be measured with Adverse Childhood Events Questionnaire. Higher scores indicate increased exposure to trauma, which have been associated with a greater risk of negative consequences. |
Baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 09.2021.848
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Familie
-
Simon Fraser UniversityUniversity of British Columbia; McMaster University; University of Victoria; Public Health Agency of Canada (PHAC) og andre samarbejdspartnereAfsluttetEffektiviteten af Nurse-Family Partnership (NFP) i BCCanada
-
Eva Morava-KoziczIkke rekrutterer endnuSLC35A2-CDG - Solute Carrier Family 35 Medlem A2 Medfødt glykosyleringslidelseForenede Stater
-
Hospital Ruber InternacionalRekrutteringRefraktær epilepsi | SLC35A2-CDG - Solute Carrier Family 35 Medlem A2 Medfødt glykosyleringslidelseSpanien